Partial Opioid Agonist class drugs

11 results

  • belbuca

    (buprenorphine hydrochloride)
    BioDelivery Sciences International Inc
    BELBUCA is indicated for the management of severe and persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not recommended for as-needed use and should be reserved for patients for whom other treatments have failed or are unsuitable.
    Medication Details
    Drug Interactions

  • brixadi

    (BUPRENORPHINE)
    Braeburn Inc.
    BRIXADI is indicated for treating moderate to severe opioid use disorder in patients who have started with a single dose of transmucosal buprenorphine or are already on buprenorphine. It should be used alongside a comprehensive treatment plan, including counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine

    (Buprenorphine)
    Amneal Pharmaceuticals NY LLC
    Buprenorphine transdermal system is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are insufficient. It is not suitable for as-needed analgesic use and is reserved for patients who cannot tolerate or achieve adequate pain control with other treatments due to risks of addiction and overdose.
    Medication Details
    Drug Interactions

  • buprenorphine

    (Buprenorphine)
    Actavis Pharma, Inc.
    Buprenorphine sublingual tablets are indicated for the treatment of opioid dependence, primarily for induction. They should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine and naloxone

    (Buprenorphine and Naloxone)
    Dr.Reddys Laboratories Inc
    Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence, to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine and naloxone

    (Buprenorphine and Naloxone)
    Dr.Reddys Laboratories Inc
    Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine hcl

    (Buprenorphine HCl)
    Hikma Pharmaceuticals USA Inc.
    Buprenorphine Sublingual Tablets are indicated for treating opioid dependence, primarily during the induction phase. They should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine hydrochloride

    (buprenorphine hydrochloride)
    Advagen Pharma Ltd
    Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence, specifically favored for induction. They should be part of a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions

  • buprenorphine hydrochloride

    (Buprenorphine Hydrochloride)
    Hospira, Inc.
    Buprenorphine hydrochloride injection is indicated for managing severe pain that requires an opioid analgesic when alternative treatments are inadequate. It is reserved for cases where non-opioid options are intolerable or ineffective, and should not be used long-term unless pain severity persists.
    Medication Details
    Drug Interactions

  • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

    (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate)
    SpecGx LLC
    Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.
    Medication Details
    Drug Interactions